Molecular genetic analysis of high risk factors developing childhood cancers and its clinical applications
儿童癌症高危因素的分子遗传学分析及其临床应用
基本信息
- 批准号:04454276
- 负责人:
- 金额:$ 4.03万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1992
- 资助国家:日本
- 起止时间:1992 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Several anti-oncogenes were studied for common childrhood cancers. Anti-oncogenes studied included p53 gene, p16/15 genes, Rb gene, DCC gene and NF1 gene. Generally, these genes tend to be mutated or deleted in cell lines more often than fresh tumor cells and in tumor cells of advanced stages and of relapsed cases. However, frequency of abnormalities of these genes varied among different tumor types. In spite of neural crest origin of both tumors, abnormalities of p53 genes were frequent seen in Ewing sarcoma but not in neuroblastoma. Abnormalities of p16/p15 genes were more frequently seen in common ALL antigen-positive acute lymphoblatic leukemia (ALL) without chromosome transloction, t (1 ; 19), than in ALL with this translocation. These abnormalies were also commn in T-ALL.Materials of non-Hodgkin lymphoma developed in 3 siblings and lung cancer in 11-year-old boy were negative for abnormalities of p53 gene. In these patients other tumor suppressor genes might be responsible for familial or rare development of their cancers.In addition to molecular study, epidemiological study was performed to find out familial clustering of common childhood cancers and constitutional factors affecting development of these cancers, using data of Japan Children's Cancer Registry (JCCR). We found that distribution of tumor types among family of children with cancer was different from that of general population. Brain tumor was more often seen in family of cancer, but colon cancer, lung cancer and cancer of bile duct were less often seen. Distribution of cancer types among parents and siblings whose family had cancers in 3 consecutive generations was different from cancer types of general population only in female and breast cancer and uterus cancer were more frequently seen.
研究了常见儿童癌症的几种抑癌基因。抑癌基因包括p53基因、p16/15基因、Rb基因、DCC基因和NF 1基因。通常,这些基因在细胞系中比在新鲜肿瘤细胞中以及在晚期和复发病例的肿瘤细胞中更常发生突变或缺失。然而,这些基因的异常频率在不同的肿瘤类型中有所不同。尽管两种肿瘤的神经嵴起源,p53基因的异常常见于尤文肉瘤,而不是在神经母细胞瘤。p16/p15基因异常在非t(1 ; 19)易位的ALL中发生率明显高于t(1 ; 19)易位的ALL。3例同胞非霍奇金淋巴瘤和1例11岁男孩肺癌标本p53基因均阴性。在这些患者中,其他肿瘤抑制基因可能是导致其癌症家族性或罕见发展的原因。除了分子研究外,还进行了流行病学研究,以了解常见儿童癌症的家族聚集性和影响这些癌症发展的体质因素,使用日本儿童癌症登记处(JCCR)的数据。发现肿瘤类型在儿童肿瘤家族中的分布与一般人群不同。肿瘤家族中以脑肿瘤多见,结肠癌、肺癌和胆管癌较少见。连续3代患癌的父母和兄弟姐妹的癌症类型分布与一般人群的癌症类型不同,仅女性癌症类型分布最多,乳腺癌和子宫癌更常见。
项目成果
期刊论文数量(66)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kojima R,Mizuguchi M.Bessho F,Oka T,Watababe H,Yonezawa M,Asano N,Iwanaka T: "Pulmonary carcinoma associated with hamartoma in an 11year old boy" Am J Pediatr Hematol/Oncol. 15. 439-442 (1993)
Kojima R、Mizuguchi M.Bessho F、Oka T、Watababe H、Yonezawa M、Asano N、Iwanaka T:“11 岁男孩与错构瘤相关的肺癌”Am J Pediatr Hematol/Oncol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Komuro H,Hayashi Y,Kawamura M,Hayashi K,Kaneko Y,Kamoshita S,Hanada R,Yamamoto K,K,Hongo T,Yamada M,Tsuchida Y: "Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastoma" Cancer Res. 53. 5284-5288 (1993)
Komuro H、Hayashi Y、Kawamura M、Hayashi K、Kaneko Y、Kamoshita S、Hanada R、Yamamoto K、K、Hongo T、Yamada M、Tsuchida Y:“p53 基因突变与尤文氏肉瘤有关,但与神经母细胞瘤无关
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kawamura M,Kikuchi A,Kobayashi S,Hanada R,Yamamoto K,Horibe K,Shikano T,Ueda K,Hayashi K,Sekiya T,Hayashi Y: "Mutation of p53 and ras genes in childhood t (1;19)-acute lymphoblastic leukemia" Blood. 85. 2546-2552 (1995)
Kawamura M、Kikuchi A、Kobayashi S、Hanada R、Yamamoto K、Horibe K、Shikano T、Ueda K、Hayashi K、Sekiya T、Hayashi Y:“儿童 t (1;19)-急性期 p53 和 ras 基因的突变
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
林泰秀,他: "Tyrosine hydroxy lase mRNAとt(11;22)-キメラmRNAを用いた神経芽腫とEwing肉腫の「遺伝子診断" 小児がん. 30. 337-340 (1993)
Yasuhide Hayashi 等人:“使用酪氨酸羟化酶 mRNA 和 t(11;22)-chimeric mRNA 进行神经母细胞瘤和尤文氏肉瘤的基因诊断。小儿癌症。30. 337-340 (1993)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
別所文雄: "Fanconi貧血を巡る諸問題" 日本小児血液学会雑誌. 7. 105-116 (1993)
Fumio Bessho:“围绕范可尼贫血的问题”日本儿科血液学会杂志 7. 105-116 (1993)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BESSHO Fumio其他文献
BESSHO Fumio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BESSHO Fumio', 18)}}的其他基金
Analysis of Expression of LAT1 in Childhood Leukemia and Effect of Inhibitors on Proliferation Inhibition
儿童白血病中LAT1的表达及抑制剂对增殖的抑制作用分析
- 批准号:
13670836 - 财政年份:2001
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Epidemiological and molecular biological study of familial factors in occurrence of children's leukemia
儿童白血病发生家族因素的流行病学及分子生物学研究
- 批准号:
09670380 - 财政年份:1997
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
網羅的なCpG siteのDNAメチル化の検索による肺腺癌のtumor suppressor geneの同定
综合寻找CpG位点DNA甲基化鉴定肺腺癌抑癌基因
- 批准号:
23K08296 - 财政年份:2023
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Modeling Breast Cancer Associated with KMT2C as a Haploinsufficient and Recessive Tumor Suppressor Gene
与作为单倍体不足和隐性肿瘤抑制基因 KMT2C 相关的乳腺癌建模
- 批准号:
491638 - 财政年份:2023
- 资助金额:
$ 4.03万 - 项目类别:
Miscellaneous Programs
Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis
正常和恶性造血过程中增强 RNA 介导的肿瘤抑制基因表达
- 批准号:
10755937 - 财政年份:2022
- 资助金额:
$ 4.03万 - 项目类别:
Comprehensive modeling of tumor suppressor gene-derived neoantigens in pancreatic cancer
胰腺癌中抑癌基因衍生的新抗原的综合建模
- 批准号:
10389366 - 财政年份:2022
- 资助金额:
$ 4.03万 - 项目类别:
SNF2 Histone Linker PHD RING Helicase as a novel tumor suppressor gene and risk factor in lung adenocarcinoma development
SNF2 组蛋白连接器 PHD RING 解旋酶作为新型抑癌基因和肺腺癌发展的危险因素
- 批准号:
472467 - 财政年份:2022
- 资助金额:
$ 4.03万 - 项目类别:
Operating Grants
Investigation of therapeutic targets in KRAS-mutant lung cancer cells co-existing multiple tumor suppressor gene mutations
共存多种抑癌基因突变的 KRAS 突变肺癌细胞治疗靶点的研究
- 批准号:
21K20793 - 财政年份:2021
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Mechanism of neuroendocrine tumor suppression by the tumor suppressor gene PHLDA3
抑癌基因PHLDA3抑制神经内分泌肿瘤的机制
- 批准号:
20H03523 - 财政年份:2020
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The Single Cell Biology of Context-Specific Responses to Loss of the RB Tumor Suppressor Gene
对 RB 肿瘤抑制基因丢失的特定反应的单细胞生物学
- 批准号:
419746 - 财政年份:2020
- 资助金额:
$ 4.03万 - 项目类别:
Operating Grants
3'UTR-dependent regulation of the PTEN tumor suppressor gene
PTEN 肿瘤抑制基因的 3UTR 依赖性调节
- 批准号:
10212969 - 财政年份:2020
- 资助金额:
$ 4.03万 - 项目类别:
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors
研究 Max 作为小细胞肺癌和其他神经内分泌肿瘤的抑癌基因
- 批准号:
10662195 - 财政年份:2020
- 资助金额:
$ 4.03万 - 项目类别:














{{item.name}}会员




